Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.53 USD | -0.20% | -0.85% | +13.06% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.06% | 375M | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.11% | 29.48B | |
+57.86% | 25.43B | |
-17.82% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Anika Therapeutics : UBS Starts Anika Therapeutics at Neutral With $46 Price Target